YONGHE MEDICAL(02279.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 75.52 million, YoY increase of 170.56%

August 20, 2026, YONGHE MEDICAL(02279.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 980.64 million, increased by 13.82% YoY; Net Profit stood at CNY 75.46 million, YoY increase of 170.89%; Profit Attributable to Shareholders stood at CNY 75.52 million, YoY increase of 170.56%; Basic Earnings Per Share (EPS) stood at CNY 0.15.
By the close of trading on August 20, 2026, YONGHE MEDICAL(02279) saw a loss of 5.79% in its share price, closing at HKD 2.36. The full-day turnover stood at HKD 663.54 thousand, with the latest market capitalization at HKD 1.24 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.